Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy

Katsuhiko Nara, Hiroshi Suzuki, Yasuyoshi Sato et al.|Supportive Care in Cancer|2023

Cited by 6